NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which of the following is NOT used for CRE coverage?

Ceftazidime/avibactam
Colistimethate
Metronidazole
Polymixin B

The correct answer is: Metronidazole

CRE coverage stands for carbapenem-resistant Enterobacteriaceae coverage. This refers to antibiotics that are effective against bacteria that are resistant to the antibiotic carbapenem. Metronidazole is not used for CRE coverage because it is not effective against carbapenem-resistant bacteria. Ceftazidime/avibactam, colistimethate, and polymixin B are all antibiotics that can be used for CRE coverage as they are effective against carbapenem-resistant bacteria.